Announcement of TTY Biopharm's unaudited income information in November 2022
2022.12.12
Provided by: TTY BIOPHARM COMPANY LIMITED
| SEQ_NO | 1 | Date of announcement | 2022/12/12 | Time of announcement | 14:14:42 |
| Subject | Announcement of TTY Biopharm's unaudited income information in November 2022 | ||||
| Date of events | 2022/12/12 | To which item it meets | paragraph 53 | ||
| Statement | 1.Date of occurrence of the event:2022/12/12 2.Company name:TTY Biopharm Co., Ltd. 3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office 4.Reciprocal shareholding ratios:N/A 5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $604,271 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $153,600 thousands, and a consolidated income before tax of $156,915 thousands in November 2022; net income attributed to stockholders of the company was $128,566 thousands; EPS is $0.52. Year-to-date consolidated net sales was $4,630,928 thousands (in NT dollars; unaudited), a consolidated operating profit was $1,169,037 thousands and consolidated income before tax was $1,336,130 thousands until November 2022; year-to-date net income attributed to stockholders of the company was $1,061,202 thousands; EPS is $4.27. 6.Countermeasures:N/A 7.Any other matters that need to be specified: The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail. |
||||